Fund: Segulah V
Sector: IT & Technology Services Investment year: 2016 Turnover: MSEK ~170 Employees: ~65 CEO: Tom Francke Chairman: Ulf Troedsson Board members: Anders Harrysson, Marcus Planting-Bergloo, Jan Amethier, Ola Romney Responsible partner: Marcus Planting-Bergloo Website: www.hermesmedical.com
Hermes is a leading global provider of advanced medical imaging software solutions within the field of nuclear medicine.
Hermes was founded in 1976 in Stockholm and serves a diversified customer base compromising prestigious hospitals and hospital networks (300+ customers) in 40+ countries worldwide. The company’s software platform Hermia is vendor-neutral and encompasses state-of-the art functionalities to visualise, analyse and quantify molecular imaging data. The software enables fast and accurate diagnosis of patients leveraging artificial intelligence.
Segulah V invested in Hermes in April 2016 to accelerate Hermes continued global expansion.